Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Not yet recruiting 5Recruiting 4Terminated 2Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3

Conditions

Triple Negative Breast Neoplasms 3Breast Neoplasms 2Neoadjuvant Therapy 1

Interventions

Specimen Handling 479pembrolizumab 454Magnetic Resonance Spectroscopy 421Carboplatin 327Cyclophosphamide 313Cisplatin 271Biopsy 270Radiotherapy 245Paclitaxel 230Gemcitabine 228Bevacizumab 211Nivolumab 188fludarabine 185venetoclax 174Drug Therapy 170Dexamethasone 158Blood Specimen Collection 158Oxaliplatin 155Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 135Radiosurgery 135Rituximab 125Pemetrexed 118durvalumab 115Leucovorin 108Radiation 107atezolizumab 105

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × famitinib × 1 year × Clear all
NCT05582499 2026-05-28

FASCINATE-N

Fudan University

Phase 2 Recruiting
716 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05749588 2026-04-16

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

Fudan University

Phase 2 Recruiting
120 enrolled
Breast

Triple Negative Breast Neoplasms

NCT06649331 2026-04-08

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Fudan University

Phase 2 Recruiting
160 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06913777 2025-06-06

Neoadjuvant SNF Precision Therapy Phase III

Fudan University

Phase 3 Recruiting
404 enrolled

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡